Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL8805297 | 1.00 | — | — | |
| Methylene Chloride SCHEMBL7211677 | 1.00 | CYP3A4 (0.35) | CYP3A4TSHRALDH1A1ALOX15HIF1A | |
| Methylene Chloride SCHEMBL2207208 | 1.00 | CYP3A4 (0.35) | CYP3A4TSHRALDH1A1ALOX15HIF1A | |
| Methylene Chloride SCHEMBL7701261 | 1.00 | CYP3A4 (0.35) | CYP3A4TSHRALDH1A1ALOX15HIF1A | |
| Water SCHEMBL16146969 | 0.93 | — | — | |
| SCHEMBL141108 | 0.93 | — | — | |
| Acetonitrile SCHEMBL4028413 | 0.84 | — | — | |
| Methyl Alcohol SCHEMBL3490957 | 0.84 | — | — | |
| Acetonitrile SCHEMBL8026268 | 0.84 | TSHR (0.32) | CYP3A4TSHRALDH1A1ALOX15HIF1A | |
| Acetone SCHEMBL4628352 | 0.77 | MCL1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846934-B2 | Substituted oxazolidinones and their use | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-09-30 | — | — | US | disclosed |
| US-20140057951-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-27 | — | — | US | disclosed |
| CN-101821259-B | Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in field of blood coagulation | BAYER HEALTHCARE AG | 2013-10-30 | — | — | CN | disclosed |
| US-8383822-B2 | Substituted oxazolidinones and their use | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-02-26 | — | — | US | disclosed |
| CN-101821259-A | Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation | BAYER HEALTHCARE AG | 2010-09-01 | — | — | CN | disclosed |
| US-20100184740-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140057951-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | XDH, MPL, OXA1L | CYP3A4 54/4885TSHR 4139/4885ALDH1A1 523/4885 |
| US-20100184740-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | XDH, MPL, OXA1L | CYP3A4 54/4885TSHR 4139/4885ALDH1A1 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.